1. Home
  2. ASIC vs MDXG Comparison

ASIC vs MDXG Comparison

Compare ASIC & MDXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ASIC

Ategrity Specialty Insurance Company Holdings

N/A

Current Price

$20.47

Market Cap

930.6M

Sector

Finance

ML Signal

N/A

Logo MiMedx Group Inc

MDXG

MiMedx Group Inc

N/A

Current Price

$3.88

Market Cap

1.0B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ASIC
MDXG
Founded
2018
2006
Country
United States
United States
Employees
203
N/A
Industry
Property-Casualty Insurers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
930.6M
1.0B
IPO Year
N/A
2007

Fundamental Metrics

Financial Performance
Metric
ASIC
MDXG
Price
$20.47
$3.88
Analyst Decision
Buy
Strong Buy
Analyst Count
4
5
Target Price
$26.75
$10.00
AVG Volume (30 Days)
80.8K
995.6K
Earning Date
05-23-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
14.29
EPS
N/A
0.32
Revenue
N/A
$418,630,000.00
Revenue This Year
$35.31
N/A
Revenue Next Year
$34.70
$13.02
P/E Ratio
$98.60
$12.13
Revenue Growth
N/A
19.99
52 Week Low
$16.35
$3.77
52 Week High
$23.88
$7.99

Technical Indicators

Market Signals
Indicator
ASIC
MDXG
Relative Strength Index (RSI) 54.04 32.75
Support Level $20.26 $3.77
Resistance Level $20.67 $7.39
Average True Range (ATR) 0.60 0.15
MACD 0.13 0.03
Stochastic Oscillator 71.48 22.47

Price Performance

Historical Comparison
ASIC
MDXG

About ASIC Ategrity Specialty Insurance Company Holdings

Ategrity Specialty Insurance Co Holdings is a specialty property and casualty insurance holding company focused on the excess and surplus market for small to medium-sized businesses (SMBs) across the United States. Operating through its subsidiaries, the company underwrites small and medium-sized commercial risks across selected industry verticals, including Retail, Real Estate, Hospitality, and Construction. Its operating model uses a technology-driven method to standardize, simplify, and, where appropriate, automate these transactions. The group distributes its products through licensed surplus lines brokers and wholesale agents.

About MDXG MiMedx Group Inc

MiMedx Group Inc develops and markets regenerative biomaterial products and bioimplants made from the human amniotic membrane, birth tissues, and human skin & bone. Its products are targeted towards the wound-care, burn, surgical, sports medicine, and orthopedics markets. MiMedx's key products are allografts processed from amniotic tissue, which include EpiFix for external use and AmnioFix for internal use. AmnioCord, AmnioFill, EpiBurn, and EpiCord are some of its other products. Also, it sells allografts for ophthalmic surgery and dental applications through licenses to third parties.

Share on Social Networks: